FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242128403> ?p ?o ?g. }

• W4242128403 endingPage "637" @default.
• W4242128403 startingPage "630" @default.
• W4242128403 abstract "PURPOSE: To provide more mature data on the efficacy and complications of a brief, dose-intense chemotherapy regimen plus radiation therapy (RT) to bulky disease sites for locally extensive and advanced-stage Hodgkin’s disease. PATIENTS AND METHODS: One hundred forty-two patients with stage III or IV or locally extensive mediastinal stage I or II Hodgkin’s disease received Stanford V chemotherapy for 12 weeks followed by 36-Gy RT to initial sites of bulky (≥ 5 cm) or macroscopic splenic disease. Freedom from progression (FFP), overall survival (OS), and freedom from second relapse (FF2R) were determined using life-table estimates. Outcomes were analyzed according to the international prognostic score. Late effects of treatment were recorded in follow-up. RESULTS: With a median follow-up of 5.4 years, the 5-year FFP was 89% and the OS was 96%. No patient progressed during treatment, and there were no treatment-related deaths. FFP was significantly superior among patients with a prognostic score of 0 to 2 compared with those with a score of 3 and higher (94% v 75%, P < .0001). No secondary leukemia was observed. To date, there have been 42 pregnancies after treatment. Among 16 patients who relapsed, the FF2R was 69% at 5 years. CONCLUSION: These data confirm our preliminary report that Stanford V chemotherapy with RT to bulky disease sites is highly effective in locally extensive and advanced Hodgkin’s disease. It is most important to compare this approach with standard doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy in the ongoing intergroup trial (E2496) to determine whether Stanford V with or without RT represents a therapeutic advance." @default.
• W4242128403 created "2022-05-12" @default.
• W4242128403 creator A5019537047 @default.
• W4242128403 creator A5029655862 @default.
• W4242128403 creator A5043886645 @default.
• W4242128403 creator A5066871392 @default.
• W4242128403 creator A5077236629 @default.
• W4242128403 creator A5078397650 @default.
• W4242128403 date "2002-02-01" @default.
• W4242128403 modified "2023-09-27" @default.
• W4242128403 title "Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial" @default.
• W4242128403 cites W18139128 @default.
• W4242128403 cites W1822884826 @default.
• W4242128403 cites W1825210192 @default.
• W4242128403 cites W1905906989 @default.
• W4242128403 cites W1940892707 @default.
• W4242128403 cites W1942009620 @default.
• W4242128403 cites W1942259007 @default.
• W4242128403 cites W1944099139 @default.
• W4242128403 cites W1965965711 @default.
• W4242128403 cites W1999348175 @default.
• W4242128403 cites W2007578756 @default.
• W4242128403 cites W2014698797 @default.
• W4242128403 cites W2033465919 @default.
• W4242128403 cites W2049458185 @default.
• W4242128403 cites W2065620512 @default.
• W4242128403 cites W2091281353 @default.
• W4242128403 cites W2122491991 @default.
• W4242128403 cites W2132922976 @default.
• W4242128403 cites W2143594378 @default.
• W4242128403 cites W2148119102 @default.
• W4242128403 cites W2156613346 @default.
• W4242128403 cites W2165308914 @default.
• W4242128403 cites W2185580724 @default.
• W4242128403 cites W2187668060 @default.
• W4242128403 cites W2262902984 @default.
• W4242128403 cites W2328676772 @default.
• W4242128403 cites W4240113087 @default.
• W4242128403 cites W4293241248 @default.
• W4242128403 doi "https://doi.org/10.1200/jco.2002.20.3.630" @default.
• W4242128403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11821442" @default.
• W4242128403 hasPublicationYear "2002" @default.
• W4242128403 type Work @default.
• W4242128403 citedByCount "50" @default.
• W4242128403 countsByYear W42421284032013 @default.
• W4242128403 countsByYear W42421284032014 @default.
• W4242128403 countsByYear W42421284032015 @default.
• W4242128403 countsByYear W42421284032016 @default.
• W4242128403 countsByYear W42421284032017 @default.
• W4242128403 countsByYear W42421284032020 @default.
• W4242128403 countsByYear W42421284032021 @default.
• W4242128403 countsByYear W42421284032022 @default.
• W4242128403 crossrefType "journal-article" @default.
• W4242128403 hasAuthorship W4242128403A5019537047 @default.
• W4242128403 hasAuthorship W4242128403A5029655862 @default.
• W4242128403 hasAuthorship W4242128403A5043886645 @default.
• W4242128403 hasAuthorship W4242128403A5066871392 @default.
• W4242128403 hasAuthorship W4242128403A5077236629 @default.
• W4242128403 hasAuthorship W4242128403A5078397650 @default.
• W4242128403 hasConcept C126322002 @default.
• W4242128403 hasConcept C141071460 @default.
• W4242128403 hasConcept C143998085 @default.
• W4242128403 hasConcept C146357865 @default.
• W4242128403 hasConcept C151730666 @default.
• W4242128403 hasConcept C2776232574 @default.
• W4242128403 hasConcept C2776305933 @default.
• W4242128403 hasConcept C2776694085 @default.
• W4242128403 hasConcept C2776755627 @default.
• W4242128403 hasConcept C2777132456 @default.
• W4242128403 hasConcept C2778336483 @default.
• W4242128403 hasConcept C2779134260 @default.
• W4242128403 hasConcept C2779429289 @default.
• W4242128403 hasConcept C2779714933 @default.
• W4242128403 hasConcept C2780964509 @default.
• W4242128403 hasConcept C2781413609 @default.
• W4242128403 hasConcept C509974204 @default.
• W4242128403 hasConcept C71924100 @default.
• W4242128403 hasConcept C86803240 @default.
• W4242128403 hasConceptScore W4242128403C126322002 @default.
• W4242128403 hasConceptScore W4242128403C141071460 @default.
• W4242128403 hasConceptScore W4242128403C143998085 @default.
• W4242128403 hasConceptScore W4242128403C146357865 @default.
• W4242128403 hasConceptScore W4242128403C151730666 @default.
• W4242128403 hasConceptScore W4242128403C2776232574 @default.
• W4242128403 hasConceptScore W4242128403C2776305933 @default.
• W4242128403 hasConceptScore W4242128403C2776694085 @default.
• W4242128403 hasConceptScore W4242128403C2776755627 @default.
• W4242128403 hasConceptScore W4242128403C2777132456 @default.
• W4242128403 hasConceptScore W4242128403C2778336483 @default.
• W4242128403 hasConceptScore W4242128403C2779134260 @default.
• W4242128403 hasConceptScore W4242128403C2779429289 @default.
• W4242128403 hasConceptScore W4242128403C2779714933 @default.
• W4242128403 hasConceptScore W4242128403C2780964509 @default.
• W4242128403 hasConceptScore W4242128403C2781413609 @default.
• W4242128403 hasConceptScore W4242128403C509974204 @default.
• W4242128403 hasConceptScore W4242128403C71924100 @default.
• W4242128403 hasConceptScore W4242128403C86803240 @default.
• W4242128403 hasIssue "3" @default.

• next